If more employers exclude weight-loss GLP-1s, patients may shift toward cash-pay programs, lower-dose options, oral drugs or cheaper clinical models
Other Weight Loss Treatments GLP-1 injections offer a unique combination of appetite suppression and metabolic benefits
Frias JP, Nauck MA, Van J et al (2018) Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
This does not mean eliminating treats entirely
Can GHK-Cu be combined with topical rapamycin for hair growth
a randomized, controlled trial